Pricing Log in Create free account

Foghorn Therapeutics Inc. (FHTX) vs Seer, Inc. (SEER)

Foghorn Therapeutics Inc. and Seer, Inc. are both Biotechnology companies. Foghorn Therapeutics Inc. and Seer, Inc. are of similar size ($113.0M and $112.2M). Foghorn Therapeutics Inc. grew revenue faster over the last twelve months: 52.0% against −12.7%. Foghorn Therapeutics Inc. has the higher net margin (−175.8% vs −478.1%) and the higher return on invested capital (0.00% vs −60.8%). Across the 17 metrics below, Foghorn Therapeutics Inc. leads on 13 and Seer, Inc. on 4.

Valuation

Metric FHTX SEER Biotechnology median
P/E n/m n/m 8.50
P/S 3.56 7.88 9.71
P/B n/m 0.50 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.24 0.64 0.64
EV/Sales (0.46) (2.87) 9.21
Earnings yield (52.97%) (60.10%) (33.15%)
Free cash flow yield (64.53%) (39.27%) (25.50%)

Profitability

Metric FHTX SEER Biotechnology median
Gross margin 100.00% 47.70% 65.16%
Operating margin (198.04%) (498.19%) 0.00%
Net margin (175.78%) (478.05%) 0.00%
Free cash flow margin (229.49%) (309.34%) 0.00%
Return on equity 81.90% (26.45%) (56.36%)
Return on assets (30.06%) (23.47%) (48.04%)
Return on invested capital 0.00% (60.78%) 0.00%

Growth

Metric FHTX SEER Biotechnology median
Revenue growth (TTM) 51.98% (12.71%) 6.02%
EPS growth (last fiscal year) 25.32% 7.91% 30.26%
Revenue growth, 5-year CAGR 135.14% 90.78% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FHTX SEER Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.36 14.74 4.72
Net debt to EBITDA 1.88 2.63 0.96

Dividend

Metric FHTX SEER Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FHTX SEER Biotechnology median
Market cap 112.24m 112.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack